title: Lysine-overproducing mutants of Saccharomyces cerevisiae baker's yeast isolated in continuous culture.
abstract: Saccharomyces cerevisiae baker's yeast mutants which produce 3 to 17 times as much lysine as the wild type, depending on the nitrogen source, have been selected. The baker's yeast strain was growth in a pH-regulated chemostat in minimal medium with proline as the nitrogen source, supplemented with increasing concentrations of the toxic analog of the lysine S-2-aminoethyl-L-cysteine (AEC). The lysine-overproducing mutants, which were isolated as AEC-resistant mutants, were also resistant to high external concentrations of lysine and to alpha-aminoadipate and seemed to be affected in the lysine biosynthetic pathway but not in the biosynthetic pathways of other amino acids. Lysine overproduction by one of the mutants seemed to be due to, at least, the loss of repression of the homocitrate synthase encoded by the LYS20 gene. The mutant grew slower than the wild type, and its dough-raising capacity was reduced in in vitro assays, probably due to the toxic effects of lysine accumulation or of an intermediate produced in the pathway. This mutant can be added as a food supplement to enrich the nutritive qualities of bakery products, and its resistance to alpha-aminoadipate, AEC, and lysine can be used as a dominant marker.
authors.affiliation: Department of Genetics, University of Seville, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Gasent-Ramírez
authors.forename: T
authors.initials: T
authors.lastname: Benítez
mesh_terms: D000596:Amino Acids / Q000378:metabolism; D003545:Cysteine / Q000031:analogs & derivatives / Q000494:pharmacology; D004271:DNA, Fungal / Q000032:analysis; D019587:Dietary Supplements; D004352:Drug Resistance, Microbial; D005285:Fermentation; D005800:Genes, Fungal; D006863:Hydrogen-Ion Concentration; D007621:Karyotyping; D008239:Lysine / Q000096:biosynthesis* / Q000235:genetics* / Q000494:pharmacology; D009154:Mutation; D007652:Oxo-Acid-Lyases / Q000235:genetics / Q000378:metabolism; D011003:Ploidies; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism*; D013172:Spores, Fungal
chemical_list: D000596:Amino Acids; D004271:DNA, Fungal; D011500:Protein Synthesis Inhibitors; C000204:S-2-aminoethyl cysteine; C021365:homocitrate synthase; D007652:Oxo-Acid-Lyases; D008239:Lysine; D003545:Cysteine